Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. All News
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about NOVARTIS AG
04:56aNovartis Signs New Deal With BioNTech to Support Production of Covid-19 Vaccine
MT
04:20aNovartis Expands Fill-and-Finish Deal with BioNTech for COVID-19 Jabs
MT
02:14aNOVARTIS : signs new initial agreement with BioNTech to support fill and finish of the mRN..
PU
01:33aNOVARTIS : extends deal to make Pfizer/BioNTech vaccines
RE
10/20Novartis in New Agreement With BioNTech to Help Manufacture Covid-19 Vaccine
DJ
10/20NOVARTIS : Global Heart Hub Roll Out Improvement Program For Cardiovascular Disease Manage..
MT
10/19NOVARTIS : Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis a..
PU
10/19PRESS RELEASE : Global Heart Hub and Novartis -2-
DJ
10/19Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world..
DJ
10/19PRESS RELEASE : Global Heart Hub and Novartis partner to tackle ASCVD, a global health cri..
DJ
10/18OYSTER POINT PHARMA : drug becomes first FDA-approved nasal spray to treat dry eyes
RE
10/14VC DAILY : Sprinter Health Collects $33 Million to Join Home-Healthcare Race
DJ
10/14NOVARTIS AG : Goldman Sachs reiterates its Buy rating
MD
10/14NOVARTIS' : Kesimpta Shows Stable Antibody Levels in Patients of Phase 3b Extension Study
MT
10/14NOVARTIS : Says Diabetic Macular Edema Drug Applications Accepted by FDA, EMA
MT
10/14NOVARTIS' : Multiple Sclerosis Therapy Shows Preservation of Immunoglobulin Levels in Rela..
MT
10/14NOVARTIS : Kesimpta® (ofatumumab) data at ECTRIMS highlights preservation of IgG levels an..
PU
10/13NOVARTIS' : Supplemental Biologics License Application for Beovu Accepted in US, EU
MT
10/13NOVARTIS : announces FDA and EMA filing acceptances of Beovu® for patients with diabetic m..
PU
10/12NOVARTIS AG : Bernstein sticks Neutral
MD
10/11GLOBAL MARKETS LIVE : Facebook, Apple, KKR, Adler, Roche...
10/11ANALYST RECOMMANDATIONS : AstraZeneca, Comcast, Exxon, Starbucks...
10/11NOVARTIS : Berenberg Lowers Price Target on Novartis, Maintains Buy Recommendation
MT
10/11NOVARTIS : Unit Closes Purchase of GlaxoSmithKline's Cephalosporin Antibiotics Business
MT
10/11NOVARTIS : Sandoz completes acquisition of GSK's cephalosporin business, reinforcing leadi..
AQ
10/11PRESS RELEASE : Novartis: Sandoz completes acquisition of GSK's cephalosporin business, re..
DJ
10/11NOVARTIS : Sandoz completes acquisition of GSK's cephalosporin business, reinforcing leadi..
DJ
10/11NOVARTIS AG : Berenberg reaffirms its Buy rating
MD
10/10NOVARTIS : Tencent to Expand AI Partnership to WeChat
MT
10/08NOVARTIS AG : Buy rating from UBS
MD
10/07NOVARTIS AG : Buy rating from Jefferies
MD
10/07NOVARTIS : to present broad range of portfolio data at ECTRIMS, reinforcing long-standing ..
PU
10/06Health Care Sits Out Broader Market Advance This Afternoon
MT
10/06Health Care Stocks Struggling in Wednesday Markets Slide
MT
10/06GLOBAL MARKETS LIVE : LVMH, Pepsico, Tesco, Visa, Novartis...
10/06RAFAEL : Hires Dr. Mary Margaret Huizinga as Chief Development and Medical Officer
MT
10/05NOVARTIS' : Canadian Unit Joins Innodem Neurosciences to Study Multiple Sclerosis Diagnosi..
MT
10/05NOVARTIS AG : Sell rating from JP Morgan
MD
10/05VALEO PHARMA : Completes Negotiations with Pan-Canadian Pharmaceutical Alliance For Two As..
MT
10/05NOVARTIS' : Sickle Cell Disease Treatment Gets UK Public Body's Recommendation
MT
10/05Novartis' Adakveo Receives NICE Recommendation for Preventing Recurrent Vaso-Occlusive ..
CI
10/04GLOBAL MARKETS LIVE : Evergrande, Facebook, Merck, Tesla, WM Morrison...
10/04Novartis, Other Swiss Companies Require Staff To Show COVID-19 Certificates
MT
10/03NOVARTIS : Unit Sandoz to Pay $185 Million in US Pricing Investigation Settlement
MT
10/01NOVARTIS : Taro Pharmaceutical Units Part of About $447 Million DOJ Settlement Over Price-..
MT
10/01DOJ Says Three Generic Drug Companies Resolve Price-Fixing Allegations -- Update
DJ
10/01NOVARTIS : Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regar..
AQ
10/01PRESS RELEASE : Novartis: Sandoz Resolves Legacy Federal Government Civil Investigation in..
DJ
10/01NOVARTIS : Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regar..
DJ
10/01DOJ Says Three Generic Drug Companies Resolve Price-Fixing Allegations
DJ
10/01H LUNDBECK A/S : U.S. court issues decision in Trintellix patent litigation upholding acti..
AQ
10/01NOVARTIS : Enabling our associates to work safely on our sites
PU
10/01NOVARTIS : COVID-19 news feed
PU
09/30NOVARTIS' : Chronic Hives Therapy Shows Rapid Disease Control Activity in Mid-Stage Trial
MT
09/30GLOBAL MARKETS LIVE : Boeing, Walgreens, Dufry, M&S, Novartis...
09/30NOVARTIS : data show rapid and effective disease activity control with remibrutinib (LOU06..
PU
09/30NOVARTIS : New data reinforce efficacy and convenience of Novartis Cosentyx (secukinumab) ..
AQ
09/30NOVARTIS : Affirms 2040 Net Zero Carbon Targets, Makes Progress on Patient Access Program
MT
09/30PRESS RELEASE : Novartis accelerates efforts -2-
DJ
09/30PRESS RELEASE : Novartis accelerates efforts toward ESG targets to increase access to medi..
DJ
09/30Novartis accelerates efforts toward ESG targets to increase access to medicines, improv..
DJ
09/29Novartis, Partner Say Phase 2b Study on Children's Malaria Treatment Shows Encouraging ..
DJ
09/29NOVARTIS : Combination Therapy Reduces Malaria Parasites in Mid-Stage Trial
MT
09/29NOVARTIS : and Medicines for Malaria Venture report positive results for Phase 2b study of..
PU
09/29NOVARTIS : Says Cosentyx Showed Positive Results in Plaque Psoriasis Trial
MT
09/29FUSION PHARMACEUTICALS : Names Mohit Rawat as President and Chief Business Officer
MT
09/29NOVARTIS' : Cosentyx Autoinjector Shows High Efficacy In Late-Stage Trial In Psoriasis Pat..
MT
09/29NOVARTIS : Drug Proves More Effective For Control Of Chronic Hives Symptoms Than Omalizuma..
MT
09/29NOVARTIS : New data reinforce efficacy and convenience of Novartis Cosentyx® (secukinumab)..
PU
09/29NOVARTIS : data show achieving complete control of chronic spontaneous urticaria (CSU) imp..
PU
09/28NOVARTIS : Gets US FDA's Priority Review For Castration-Resistant Prostate Cancer Therapy
MT
09/28Novartis Lining Up More Potent COVID-19 Antiviral Pills Rivaling Merck, Pfizer
MT
09/28NOVARTIS : Teams Up With Jefferson Health To Improve Health Conditions Of Philadelphia's C..
MT
09/28Artios Doses First Patient in Phase 1/2a Study of Pol? Inhibitor ART4215
DJ
09/28NOVARTIS : FDA grants Priority Review for investigational targeted radioligand therapy 177..
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVARTIS AG
10/26/21